A message from PROMETRIKA’s President and CEO
The Global COVID-19 pandemic is having a profound impact on communities and individuals worldwide. Our daily lives have changed drastically and the sequelae of this pandemic are likely to be long-lasting. PROMETRIKA continues to monitor the evolving picture of COVID-19 spread worldwide as well as the pharmaceutical and biotechnology companies’ and clinical research community’s extraordinary and tireless efforts to combat this disease by developing vaccines and novel treatments. In these unprecedented times, we remain focused and committed to our core values of excellence, flexibility, and above all caring for the well-being of our sponsors, patients, employees and their families.
“Closing The Real-World Evidence Gap: Pragmatic Clinical Trials & Observational Studies”
Full Service CRO earns accreditation in Rave Targeted Source Document Verification (TSDV) tool, their fourth accredited module in Medidata’s suite of clinical research products.
We are excited to announce the launch of PROMETRIKA’s newly redesigned website!
Barry Mirrer has joined PROMETRIKA’s Leadership Team as Head of Quality Assurance
Follow Us